Loading organizations...
Aberdeen Investments, operating as Aberdeen Group plc, is an asset management company based in Edinburgh, Scotland, providing investment funds and portfolio services to institutional and private investors worldwide. As a publicly listed constituent of the FTSE 250 Index on the London Stock Exchange, the firm generates revenue through management fees across its global offices. The organization engages in significant global market transactions, notably selling its shares in South African retailer Massmart to Walmart for approximately $377.6 million in November 2022. Previously operating under the brand name abrdn, the firm officially reverted its trading identity to Aberdeen in March 2025 following leadership periods involving former chair Douglas Flint. The current entity traces its historical roots to a merger with Standard Life, originally established in 1825, while the core Aberdeen Asset Management business was founded in 1983.
Aberdeen Investments serves a diverse client base, including individuals managing their own savings and investments, financial advisors, wealth managers, and institutional investors.
Aberdeen Investments is dedicated to offering client service supported by cutting-edge technology and personnel, and also develops AI-driven investment analysis tools.
Aberdeen Investments serves a diverse client base, including individuals managing their own savings and investments, financial advisors, wealth managers, and institutional investors.
Aberdeen Investments is dedicated to offering client service supported by cutting-edge technology and personnel, and also develops AI-driven investment analysis tools.
Aberdeen Investments operates as an investment firm dedicated to assisting investors in achieving their financial objectives. The firm provides a range of investment options and services, positioning itself as a global specialist asset manager.
Aberdeen Investments caters to a broad spectrum of clients, including individuals managing personal savings and investments, financial advisors, and wealth managers. Additionally, the firm serves institutional investors, offering tailored solutions to meet their specific needs.
Its offerings encompass various investment vehicles, such as closed-end funds, mutual funds, and Exchange Traded Funds (ETFs). These products are designed to provide diverse avenues for capital allocation across different market segments.
The firm emphasizes client service, supported by advanced technology and personnel. Aberdeen Investments also develops AI-driven investment analysis tools and provides comprehensive investment management and advisory services for global investors.
Recent activities include the launch of new Article 8 funds, which incorporate World, American, and European equity enhanced index strategies. The firm has also advised on significant real estate transactions, such as a UK Real Estate Fund's entry into single-family housing.
Aberdeen Investments maintains its headquarters in Philadelphia, Pennsylvania, and focuses on delivering investment solutions to its client base.
Aberdeen Investments has 1 tracked investment across 1 company. The latest tracked deal is $52.0M Series A in Third Arc Bio in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 4, 2026 | Third Arc Bio | $52.0M Series A | Andreessen Horowitz | AbbVie, Alderline Group, Biotechnology Value Fund, Galapagos, Goldman Sachs Alternatives, Hillhouse Investment, Marshall Wace, Omega Funds, T. Rowe Price, Abrdn, BVF Partners, Freepoint Capital Group, 高盛 |
